NVO US
NVO US Novo Nordisk A/S Sponsored ADR Class B BATS:NVO A3MInvestments The decline in Novo Nordisk shares is not the result of a single factor, but rather the result of a complex set of fundamental issues: weakening financial performance, loss of competitive advantage in key products, and increased strategic risks. While negative data on Eli […]
A Healthy Dose Of Competition Sends Weight-Loss Drug Prices Plummeting
Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?
Pharmalittle: We’re reading about failed Novo Alzheimer’s trials, favorable Bayer stroke results, and more
Good morning, Jason Mast here filling in for Ed. Happy turkey week to all. I, for one, have always detested that dry, tasteless bird. (It’s sides and brisket for me, followed by pecan pie.) So in their interest, I leave you with this story, from 2018, about the Ozark turkeys that fell from the sky. […]
Novo Nordisk says Alzheimer’s drug trial fails to meet main goal
Novo Nordisk’s shares fell 10% after the company said its oral semaglutide drug Rybelsus failed to meet the main goal in late-stage trials testing whether it could slow cognitive decline in early Alzheimer’s patients. The setback dims hopes for expanding GLP-1 medicines into a major new market beyond obesity and diabetes, reinforcing scepticism over Novo’s […]
诺和诺德能否凭借GLP-1的阿尔茨海默病数据终结礼来股价上涨势头 – Seeking Alpha
Can Novo unravel Lilly rally with Alzheimer’s data for GLP-1 (news.google.com) 11-23 #Seeking Alpha
Will Americans ever be able to afford weight loss drugs?
For nearly two years Nicole Cowart’s doctor recommended she take a glucagon-like peptide-1 (GLP-1) receptor agonist. The doctor said it would help her manage her prediabetes and leg swelling—but her insurance wouldn’t pay unless she was diagnosed with type 2 diabetes.Cowart ran out of treatment options and remembers her doctor hoping that she would develop […]
Muscly people show slower brain ageing, study finds
Research highlights possible drawback of muscle mass loss through use of GLP-1 anti-obesity drugs
24th November – Threat Intelligence Report
For the latest discoveries in cyber research for the week of 24th November, please download our Threat Intelligence Bulletin. Introduction to Malware Binary Triage (IMBT) Course Looking to level up your skills? Get 10% off using coupon code: MWNEWS10 for any flavor. Enroll Now and Save 10%: Coupon Code MWNEWS10 Note: Affiliate link – your […]
GLP-1 side effects – LAist
GLP-1 side effects LAist Brain scientists are seeking weight-loss drugs without the nausea : Shots – Health News NPR Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide Nature Better Than Ozempic? New Oxytocin Combination Could Eliminate Side Effects SciTechDaily GLP-1 Drug May Offer Short-Term Control of Obsessive Food Cravings U.S. News & World Report
GLP-1 Receptor Agonists Linked to Lower Infection Risk
GLP-1 receptor agonists are associated with a lower risk for serious infections, a recent meta-analysis suggests. Medscape Medical News